{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:44:34Z","timestamp":1791204274065,"version":"4.2.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ebiom.2020.102887","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T22:55:29Z","timestamp":1595976929000},"page":"102887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5770","authenticated-orcid":false,"given":"Pere","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Corominas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-1827","authenticated-orcid":false,"given":"Jordi","family":"Casademont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"de Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102887_bib0001","unstructured":"WHO. Novel coronavirus \u2013 China. Jan 12, 2020. http:\/\/www.who.int\/csr\/don\/12-january-2020-novel-coronavirus-china\/en\/ (accessed May 20, 2020)."},{"key":"10.1016\/j.ebiom.2020.102887_bib0002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0003","unstructured":"Johns Hopkins. https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"10.1016\/j.ebiom.2020.102887_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biologic perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ebiom.2020.102887_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2020.102887_bib0006","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/infdis\/jiy083","article-title":"The damage-response framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases","volume":"218","author":"Pirofski","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102887_bib0007","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102887_bib0008","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0009","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1371\/journal.pbio.0060226","article-title":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum","volume":"6","author":"Knoops","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.ebiom.2020.102887_bib0011","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102887_bib0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102887_bib0013","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0014","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102887_bib0015","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102887_bib0016","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0017","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0018","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1128\/JVI.02501-05","article-title":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex","volume":"80","author":"Snijder","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0019","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/Golgi membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/bs.aivir.2016.08.006","article-title":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response","volume":"96","author":"Kindler","year":"2016","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0021","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/JVI.02472-07","article-title":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells","volume":"82","author":"Narayanan","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0022","doi-asserted-by":"crossref","first-page":"e30802","DOI":"10.1371\/journal.pone.0030802","article-title":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102887_bib0023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2008.01.001","article-title":"Interferon and cytokine responses to SARS-coronavirus infection","volume":"19","author":"Thiel","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ebiom.2020.102887_bib0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01721-16","article-title":"The conserved coronavirus macrodomain promotes virulence and suppresses the innate immune response during severe acute respiratory syndrome coronavirus infection","volume":"7","author":"Fehr","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2020.102887_bib0026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/cmi.2013.61","article-title":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain","volume":"11","author":"Siu","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa410","article-title":"Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19","author":"Chu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102887_bib0028","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0029","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell Subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102887_bib0031","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102887_bib0032","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2020.102887_bib0033","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0034","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0036","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.2067","article-title":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","volume":"210","author":"He","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0037","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2007.04.009","article-title":"Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappa B","volume":"365","author":"Zhang","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.ebiom.2020.102887_bib0038","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappa B pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0042","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.16659","article-title":"Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients","volume":"189","author":"Wan","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0043","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102887_bib0044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.chom.2013.12.003","article-title":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival","volume":"15","author":"Rodrigue-Gervais","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2020.102887_bib0045","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0046","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm1633","article-title":"Adaptive immune cells temper initial innate responses","volume":"13","author":"Kim","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0047","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0048","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2020.102887_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6491738","article-title":"Middle east respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development","volume":"2019","author":"Mubarak","year":"2019","journal-title":"J Immunol Res"},{"issue":"Pt 1","key":"10.1016\/j.ebiom.2020.102887_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20050698","article-title":"Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors","volume":"392","author":"Yang","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.ebiom.2020.102887_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0498-4","article-title":"SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0052","doi-asserted-by":"crossref","unstructured":"Yang M. Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV Infection (2020). Available at SSRN: http:\/\/dx.doi.org\/10.2139\/ssrn.3527420","DOI":"10.2139\/ssrn.3527420"},{"key":"10.1016\/j.ebiom.2020.102887_bib0053","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe acute respiratory syndrome coronavirus Viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0054","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1462-5822.2006.00751.x","article-title":"Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages","volume":"8","author":"Fink","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0055","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2020.102887_bib0056","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20499","article-title":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","volume":"78","author":"Zhang","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0058","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0059","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2020.102887_bib0060","first-page":"12","article-title":"Kidneys and fluids in pressure regulation. Small volume but large pressure changes","volume":"19","author":"Guyton","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2020.102887_bib0061","first-page":"467","article-title":"Purification and properties of angiotensin I-converting enzyme in human lung and its role on the metabolism of vasoactive peptides in pulmonary circulation","volume":"120B","author":"Kokubu","year":"1979","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0062","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1590\/S0100-879X2002000900001","article-title":"Recent advances in angiotensin II signaling","volume":"35","author":"Touyz","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0063","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0064","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0065","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1210\/en.2004-0443","article-title":"The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis","volume":"145","author":"Douglas","year":"2004","journal-title":"Endocrinology"},{"issue":"3 Pt 2","key":"10.1016\/j.ebiom.2020.102887_bib0066","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.HYP.0000052947.60363.24","article-title":"Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7)","volume":"41","author":"Santos","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2020.102887_bib0067","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0068","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/Angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0069","first-page":"98","article-title":"Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019","volume":"6","author":"Liu","year":"2020","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/138161212799436593","article-title":"Role of renin-angiotensin system in inflammation, immunity and aging","volume":"18","author":"Capettini","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ebiom.2020.102887_bib0071","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCRESAHA.110.219279","article-title":"(2010). Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse","volume":"107","author":"Thomas","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0072","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102887_bib0073","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH12-06-0396","article-title":"The angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis: a potential target for treating thrombotic diseases","volume":"108","author":"Fraga-Silva","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.ebiom.2020.102887_bib0076","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102887_bib0077","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0078","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.ebiom.2020.102887_bib0079","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11335","article-title":"Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"3","author":"Parasa","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2020.102887_bib0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ebiom.2020.102887_bib0081","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1871528113666140713164506","article-title":"ACE and ACE2 in inflammation: a tale of two enzymes","volume":"13","author":"Gaddam","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.ebiom.2020.102887_bib0082","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1-7), and Mas: the other side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pfl\u00fcg Arch"},{"key":"10.1016\/j.ebiom.2020.102887_bib0083","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS_CoV-2 glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102887_bib0084","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0085","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0086","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2020.102887_bib0087","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0088","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0089","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/CCM.0000000000000713","article-title":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients* multicenter study; randomized controlled trial","volume":"43","author":"Lim","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0091","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1055\/s-0039-1696942","article-title":"Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism?","volume":"45","author":"Marongiu","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0092","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","article-title":"Understanding infection-induced thrombosis: lessons learned from animal models","volume":"10","author":"Beristain-Covarrubias","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0093","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","author":"Connors","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0094","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2020.102887_bib0095","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity - a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0096","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0097","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ebiom.2020.102887_bib0098","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-2004-833481","article-title":"Platelet coagulation-protein interactions","volume":"30","author":"Walsh","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0099","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2020.102887_bib0100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/hr.2011.137","article-title":"Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome","volume":"34","author":"Fogari","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0101","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/thoraxjnl-2013-204367","article-title":"Proteinase-activated receptors in fibroproliferative lung disease","volume":"69","author":"Jos\u00e9","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.ebiom.2020.102887_bib0102","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1182\/blood-2012-09-459156","article-title":"Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-\/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation","volume":"121","author":"Fang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2020.102887_bib0103","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","article-title":"The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets","volume":"14","author":"Fraga-Silva","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0104","article-title":"High frequency of antiphospholipid antibodies in critically-ill COVID-19 patients: a link with hypercoagulability?","author":"Pineton de Chambrun","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0105","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jss.2013.06.012","article-title":"Hypercoagulability in response to elevated body temperature and central hypovolemia","volume":"185","author":"Meyer","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0106","article-title":"COVID-19, prothrombotic factors and venous thromboembolism","author":"Schulman","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ebiom.2020.102887_bib0107","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/978-0-387-33012-9_85","article-title":"Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization","volume":"581","author":"Jia","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0109","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal gene expression of angiotensin-converting enzyme 2 in children and adults","volume":"323","author":"Bunyavanich","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2020.102887_bib0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jmv.25785","article-title":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19","volume":"92","author":"Cheng","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0111","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0112","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0113","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.110.153668","article-title":"Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats","volume":"56","author":"Sullivan","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2020.102887_bib0114","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316642915","article-title":"Fructose-rich diet induces gender-specific changes in expression of the renin-angiotensin system in rat heart and upregulates the ACE\/AT1R axis in the male rat aorta","volume":"17","author":"Bundalo","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ebiom.2020.102887_bib0115","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.celrep.2016.07.003","article-title":"Suppression of resting metabolism by the angiotensin AT2 receptor","volume":"16","author":"Littlejohn","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2020.102887_bib0116","unstructured":"Intensive Care National Audit & Research Centre (ICNARC). Covid-19 report. https:\/\/www.icnarc.org\/Our-Audit\/Audits\/Cmp\/Reports. Accessed May 7 2020."},{"key":"10.1016\/j.ebiom.2020.102887_bib0117","unstructured":"Istituto Superiore de Sanit\u00e0. Characteristics of COVID-19 patients dying in Italy report based on available data on April 2nd, 2020. https:\/\/www.epicentro.iss.it\/en\/coronavirus\/bollettino\/Report-COVID-2019_2_april_2020.pdf. Accessed May 7 2020."},{"key":"10.1016\/j.ebiom.2020.102887_bib0118","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22844","article-title":"Targeting the adipose tissue in COVID-19","author":"Malavazos","year":"2020","journal-title":"Obes Silver Spring"},{"key":"10.1016\/j.ebiom.2020.102887_bib0119","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.humimm.2019.04.011","article-title":"Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women","volume":"80","author":"Adebamowo","year":"2019","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0120","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3174868","article-title":"An Increased frequency in HLA class I alleles and haplotypes suggests genetic susceptibility to influenza A (H1N1) 2009 pandemic: a case-control study","volume":"2018","author":"Falf\u00e1n-Valencia","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0121","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2017.01.014","article-title":"Pattern recognitions receptors in immunodeficiency disorders","volume":"808","author":"Mortaz","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0122","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1074\/jbc.M117.784470","article-title":"The R753Q polymorphism in Toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2","volume":"292","author":"Pattabiraman","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2020.102887_bib0123","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-4-9","article-title":"Association of HLA class I with severe acute respiratory syndrome coronavirus infection","volume":"12","author":"Lin","year":"2003","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0124","doi-asserted-by":"crossref","first-page":"e00510","DOI":"10.1128\/JVI.00510-20","article-title":"Human leukocyte antigen susceptibility map for SARS-CoV-2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0125","doi-asserted-by":"crossref","first-page":"e3855","DOI":"10.1097\/MD.0000000000003855","article-title":"Circulating interleukin-6 and rheumatoid arthritis: a Mendelian randomization meta-analysis","volume":"95","author":"Li","year":"2016","journal-title":"Med Baltim"},{"key":"10.1016\/j.ebiom.2020.102887_bib0126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jcpt.12625","article-title":"Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites","volume":"43","author":"Chen","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ebiom.2020.102887_bib0127","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cca.2020.03.031","article-title":"The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections","volume":"505","author":"Delanghe","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ebiom.2020.102887_bib0128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","article-title":"Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19","volume":"222","author":"Zhang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102887_bib0129","article-title":"Genomewide Association study of severe Covid-19 with respiratory failure","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0130","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0131","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41423-020-0385-z","article-title":"Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0132","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.ebiom.2020.102887_bib0133","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102887_bib0134","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","article-title":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide induced lung injury in piglets","volume":"38","author":"Treml","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2020.102887_bib0136","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102887_bib0137","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0138","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0139","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study","volume":"81","author":"Deng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2020.102887_bib0141","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ebiom.2020.102887_bib0142","unstructured":"Statement from the chief investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020.https:\/\/www.recoverytrial.net\/results. Accessed June 22, 2020."},{"key":"10.1016\/j.ebiom.2020.102887_bib0143","unstructured":"\u201cSolidarity\u201d clinical trial for COVID-19 treatments. Update on hydroxychloroquine.https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments. Accessed June 22, 2020"},{"key":"10.1016\/j.ebiom.2020.102887_bib0144","unstructured":"NIH halts clinical trial of hydroxychloroquine. Study shows treatment does no harm, but provides no benefit. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-halts-clinical-trial-hydroxychloroquine. Accessed June 22, 2020."},{"key":"10.1016\/j.ebiom.2020.102887_bib0145","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0146","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0147","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0148","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014 preliminary report","author":"Beigel","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102887_bib0149","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102887_bib0150","unstructured":"Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. https:\/\/www.recoverytrial.net\/news\/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19. Accessed, June 24, 2020."},{"key":"10.1016\/j.ebiom.2020.102887_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ebiom.2020.102887_bib0152","first-page":"529","article-title":"Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19","volume":"38","author":"Sciascia","year":"2020","journal-title":"Clin Exp Rheumathol"},{"key":"10.1016\/j.ebiom.2020.102887_bib0153","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interlekin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumathol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:02:32Z","timestamp":1762455752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420302620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":153,"alternative-id":["S2352396420302620"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102887","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102887"}}